Katherine L. Farley

Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia

Mitch A. Phelps, Thomas S. Lin, Amy J. Johnson et al. · Blood · 2008 · 155 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition

Wenjun Ni, Jia Ji, Zunyan Dai et al. · PLoS ONE · 2010 · 54 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Development and Validation of a Highly Sensitive Liquid Chromatography/Mass Spectrometry Method for Simultaneous Quantification of Lenalidomide and Flavopiridol in Human Plasma

Qing Liu, Katherine L. Farley, Amy J. Johnson et al. · Therapeutic Drug Monitoring · 2008 · 31 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule

Mitch A. Phelps, Darlene M. Rozewski, Jeffrey S. Johnston et al. · Journal of Chromatography B · 2008 · 17 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +11

The Ecological Validity of Clinical Tests of Visuospatial Function in Community-Dwelling Older Adults

Katherine L. Farley, Christopher I. Higginson, Martin F. Sherman et al. · Archives of Clinical Neuropsychology · 2011 · 14 citations · Full text

Social Sciences, Psychology, Geriatric Assessment +16